高级检索
当前位置: 首页 > 详情页

The role of circadian clock in regulating cell functions: implications for diseases

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ ESCI

机构: [1]Infectious Diseases Institute Guangzhou Eighth People's Hospital Guangzhou Medical University Guangzhou China. [2]Guangdong TCRCure Biopharma Technology Co., Ltd. Guangzhou China. [3]College of Pharmacy Jinan University Guangzhou China. [4]School of Pharmaceutical Sciences Guangzhou University of Chinese Medicine Guangzhou China. [5]Department of Pharmacy Shenzhen Longhua District Central Hospital Shenzhen China.
出处:

关键词: cancers cell function circadian clock immune cells inflammatory diseases signaling pathway systemic diseases

摘要:
The circadian clock system orchestrates daily behavioral and physiological rhythms, facilitating adaptation to environmental and internal oscillations. Disruptions in circadian rhythms have been linked to increased susceptibility to various diseases and can exacerbate existing conditions. This review delves into the intricate regulation of diurnal gene expression and cell function by circadian clocks across diverse tissues. . Specifically, we explore the rhythmicity of gene expressions, behaviors, and functions in both immune and non-immune cells, elucidating the regulatory effects and mechanisms imposed by circadian clocks. A detailed discussion is centered on elucidating the complex functions of circadian clocks in regulating key cellular signaling pathways. We further review the circadian regulation in diverse diseases, with a focus on inflammatory diseases, cancers, and systemic diseases. By highlighting the intimate interplay between circadian clocks and diseases, especially through clock-controlled cell function, this review contributes to the development of novel disease intervention strategies. This enhanced understanding holds significant promise for the design of targeted therapies that can exploit the circadian regulation mechanisms for improved treatment efficacy.© 2024 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
JCR分区:
出版当年[2022]版:
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Infectious Diseases Institute Guangzhou Eighth People's Hospital Guangzhou Medical University Guangzhou China. [2]Guangdong TCRCure Biopharma Technology Co., Ltd. Guangzhou China.
共同第一作者:
通讯作者:
通讯机构: [1]Infectious Diseases Institute Guangzhou Eighth People's Hospital Guangzhou Medical University Guangzhou China. [4]School of Pharmaceutical Sciences Guangzhou University of Chinese Medicine Guangzhou China. [*1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. [*2]Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号